diabetes

GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity, but they come with side effects. Physicians say the benefits outweigh the risks.

Targeting a gut bacterial species or its metabolites could potentially improve diabetes management by reducing sugar preferences. 

Injectable micelles that release glucagon could provide a new way to treat hypoglycemic events in diabetes.

Customizable hydrogels could make taking diabetes and cancer medications as well as other biologics easier for patients.

Once symptoms show up, it’s too late to cure many autoimmune diseases. Researchers are investigating ways to prevent the conditions from starting at all.

Dopamine stimulators may lessen the systemic side effects — often weight gain and diabetes — of dopamine-blocking antipsychotics.

Researchers discovered a new gene required for pancreas development, but much to their surprise, they found that it was absent in all animals except primates.

Targeting a gut microbial enzyme could potentially improve treatment for type 2 diabetes.

The discovery of insulin and its role in diabetes began with extracting canine pancreatic secretions and culminated in the first artificial pancreas in 2016. 

Researchers developed ingestible capsules that inject drugs into the stomach and small intestine, providing a novel oral delivery method for biologics.